Showing 1031-1040 of 1635 results for "".
- LabCorp, Quest Broaden Availability of COVID-19 Tests Nationwidehttps://modernod.com/news/labcorp-quest-broaden-availability-of-covid-19-tests-nationwide/2477766/The U.S. clinical testing giants Quest Diagnostics and LabCorp are broadening the availability of their COVID-19 diagnostic tests, opening up their use nationwide, according to a FierceBiotech
- NIH Mobilizes National Innovation Initiative For COVID-19 Diagnosticshttps://modernod.com/news/nih-mobilizes-national-innovation-initiative-for-covid-19-diagnostics/2477698/The National Institutes of Health (NIH) announced a new initiative aimed at speeding innovation, development, and commercialization of COVID-19 testing technologies. With a $1.5 billion investment from federal stimulus funding, the newly launched Rapid Acceleration of Diagnostics (RADx) in
- Quest, LabCorp Launch Nationwide COVID-19 Antibody Testing in Pharmacies and Onlinehttps://modernod.com/news/quest-labcorp-launch-nationwide-covid-19-antibody-testing-in-pharmacies-and-online/2477677/Weeks after launching their own COVID-19 molecular testing initiatives, lab giants Quest Diagnostics and LabCorp have begun offering antibody tests nationwide for the next phase of the coronavirus pandemic, according to a FierceBiotech
- BVI Names David Murray as Chief Financial Officerhttps://modernod.com/news/bvi-names-david-murray-as-chief-financial-officer/2477662/BVI announced that it has named David Murray as Chief Financial Officer. Most recently, Mr. Murray served as Chief Financial Officer of Alcon from 2015 until its $30bn spin-off from Novartis Group AG in 20
- National Vision Announces Plans For the Gradual Reopening of Retail Locations to the Publichttps://modernod.com/news/national-vision-announces-plans-for-the-gradual-reopening-of-retail-locations-to-the-public/2477644/National Vision Holdings announced plans for the gradual reopening of retail locations to the public with enhanced safety protocols and a focus on meeting the essential, urgent and emergency eye health needs of patients and customers, according to a company news release. Beginning April 27
- LambdaVision Wins NASA Award to Further Advance Development of an Artificial Retinahttps://modernod.com/news/lambdavision-wins-nasa-award-to-further-advance-development-of-an-artificial-retina/2477556/LambdaVision, along with implementation partner, Space Tango, has been selected by NASA for an award of $5 million. This new funding will support LambdaVision’s development of the first protein-based artificial retina to restore meaningful vision for patients who are blind or have lost significan
- Gottlieb, Mostashari Propose National COVID-19 Surveillance Systemhttps://modernod.com/news/gottlieb-mostashari-propose-national-covid-19-surveillance-system/2477555/Five healthcare experts—including former top government healthcare officials Scott Gottlieb and Farzad Mostashari—have proposed a plan to build a national COVID-19 surveillance system, according to a FierceHealthcare
- SECO International Names Dr. R. Max Raynor as 2021 Presidenthttps://modernod.com/news/seco-international-names-dr-r-max-raynor-as-2021-president/2477497/SECO International has named R. Max Raynor, OD, as the next president. His term began on March 7, 2020, and will last through February 28, 2021. Dr. Raynor officially accepted the honor during the House of Delegates meeting held on Saturday, March 7 at SECO 20/20. “Dr. Raynor has dedicated
- Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Devicehttps://modernod.com/news/nano-retina-announces-preliminary-results-for-first-in-human-implantation-of-its-nr600-artificial-retina-device/2477482/Nano Retina, developer of the NR600, an artificial retina device that mimics the natural physiological processes of the human eye and restores functional vision to persons blinded by retinal degenerative diseases, reported preliminary results for first-in-human implantations of its artificial ret
- Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patientshttps://modernod.com/news/results-from-first-clinical-study-using-danoprevir-to-treat-naive-and-experienced-covid-19-patients/2477455/Ascletis Pharma announced the first clinical study using Ganovo (danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv. The data from this small-sample clinical study showed that danoprevir combined with ritonavir is safe and well tolerated in all p